Journal ArticleOPEN ACCESS

Fenfluramine: New treatment for seizures in Dravet Syndrome.

  • Garcia Pierce J
  • Mithal D
Pediatric Neurology Briefs (2020) 34(0)
DOI: 10.15844/pedneurbriefs-34-8
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled in the study.

Cite

CITATION STYLE

APA

Garcia Pierce, J., & Mithal, D. S. (2020). Fenfluramine: New treatment for seizures in Dravet Syndrome. Pediatric Neurology Briefs, 34(0). https://doi.org/10.15844/pedneurbriefs-34-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free